
Remdesivir improves hospitalized patient’s recovery time
The antiviral drug remdesivir (Veklury) improves the time to recovery of hospitalized COVID-19 patients, this according to a multi-center effectiveness study published in JAMA Network Open.The retrospective study, conducted by Johns Hopkins University researchers, involved 2,299 COVID-19 patients receiving care in a 5-hospital health system in the Baltimore and Washington, DC, area from March to August 2020. About 15% percent received remdesivir (342) as part of their treatment, of which 285 were matched with controls.Figure 1: Mechanism of action of Remdesivir from https://microbenotes.com/remdesivir/Clinical improvement was defined as release from the hospital without worsening of World Health Administration (WHO) severity score during hospitalization or within 28 days ...


